Enanta Pharm (NASDAQ: ENTA) reported Q2 EPS of ($0.28), versus ($2.28) reported last year. Revenue for the quarter came in at $2.2 million, versus $1.2 million reported last year.

For earnings history and earnings-related data on Enanta Pharm (ENTA) click here.